These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3081932)

  • 21. Morphine blocks and naloxone enhances suppression of operant behavior by low doses of 3-isobutyl-1-methylxanthine.
    Kleven MS; Sparber SB
    J Pharmacol Exp Ther; 1989 Jan; 248(1):273-7. PubMed ID: 2464058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meperidine effects on schedule-controlled responding.
    Leander JD; McMillan DE
    J Pharmacol Exp Ther; 1977 May; 201(2):434-43. PubMed ID: 859106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute sensitization to opioid antagonists.
    White-Gbadebo D; Holtzman SG
    Pharmacol Biochem Behav; 1994 Mar; 47(3):559-66. PubMed ID: 8208774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerance to antinociceptive effects of morphine without tolerance to its effects on schedule-controlled behavior.
    Solomon RE; Wasserman EA; Gebhart GF
    Psychopharmacology (Berl); 1987; 92(3):327-33. PubMed ID: 3114785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification of behavioral effects of morphine, meperidine and normeperidine by naloxone and by morphine tolerance.
    Witkin JM; Leander JD; Dykstra LA
    J Pharmacol Exp Ther; 1983 May; 225(2):275-83. PubMed ID: 6842391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naloxone and diprenorphine reduce responding for brain self-stimulation in a fixed-ratio schedule in rats.
    Schaefer GJ; Michael RP
    Pharmacol Biochem Behav; 1988 Jan; 29(1):209-12. PubMed ID: 3353428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of LY150720 (picenadol), a novel mixed-action opioid, on schedule-controlled responding in the squirrel monkey.
    Carter RB; Dykstra LA
    Pharmacol Biochem Behav; 1984 Nov; 21(5):779-86. PubMed ID: 6514768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of morphine, meperidine, anileridine, and alphaprodine on schedule-controlled responding and analgesia.
    Leander JD
    Pharmacol Biochem Behav; 1980 May; 12(5):797-801. PubMed ID: 6104822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs.
    Higgins GA; Sellers EM
    Pharmacol Biochem Behav; 1994 May; 48(1):1-8. PubMed ID: 8029278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J; Schulteis G
    Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schedule-controlled behavior in the morphine-dependent and post-dependent rat.
    Brady LS; Holtzman SG
    Psychopharmacology (Berl); 1980; 70(1):11-8. PubMed ID: 6775328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction of d-amphetamine and naloxone differs for rats trained on separate fixed-interval or fixed-ratio schedules of reinforcement.
    Andrews JS; Holtzman SG
    Pharmacol Biochem Behav; 1987 Jan; 26(1):167-71. PubMed ID: 3562487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of phencyclidine, haloperidol, and naloxone on fixed-interval performance in rats.
    Wagner GC; Masters DB; Tomie A
    Psychopharmacology (Berl); 1984; 84(1):32-8. PubMed ID: 6436887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new progressive ratio schedule for support of morphine self-administration in opiate dependent rats.
    Grasing K; Li N; He S; Parrish C; Delich J; Glowa J
    Psychopharmacology (Berl); 2003 Aug; 168(4):387-96. PubMed ID: 12732925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using antagonists to assess neurochemical coding of a drug's ability to establish a conditioned place preference.
    Bilsky EJ; Marglin SH; Reid LD
    Pharmacol Biochem Behav; 1990 Nov; 37(3):425-31. PubMed ID: 2087483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereoselective behavioral effects of N-allylnormetazocine in pigeons and squirrel monkeys.
    Katz JL; Spealman RD; Clark RD
    J Pharmacol Exp Ther; 1985 Feb; 232(2):452-61. PubMed ID: 3968644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naloxone administration impairs autoshaped learning.
    Messing RB; Allen SJ; Aanonsen L; Sparber SB
    Behav Neural Biol; 1989 Jan; 51(1):34-45. PubMed ID: 2705981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclazocine disruption of operant behavior is antagonized by naloxone and metergoline.
    Henck JW; Mokler DJ; Commissaris RL; Rech RH
    Pharmacol Biochem Behav; 1983 Jan; 18(1):41-5. PubMed ID: 6828536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.
    Picker MJ; Negus SS; Powell KR
    Psychopharmacology (Berl); 1991; 103(1):129-35. PubMed ID: 1848712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naloxone enhances the expression of morphine-induced conditioned place preference.
    Neisewander JL; Pierce RC; Bardo MT
    Psychopharmacology (Berl); 1990; 100(2):201-5. PubMed ID: 2305008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.